 |  | 










Subscribe to our Email List



|  | 


| | | Professor Michael Walker, PhD
Chief Executive Officer Professor Walker has been a director and CEO of Verona Pharma since September 2006. He is an Emeritus Professor at the Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Canada and has founded and managed various biotech companies in Canada and the UK. His research interests are wide including many aspects of general pharmacology (from basic to clinical studies), marine toxins and respiratory and cardiac pharmacology. Professor Walker was the founder of Rhythm Search Developments (RSD) Ltd., which company evolved into Nortran Pharmaceuticals Inc. and subsequently Cardiome Pharma Corp. (TSX:COM, NASDAQ: CRME) whose drug, RSD1235, for the acute termination of atrial fibrillation (a disorder of heart beating), is currently the subject of a New Drug Application filed with the US Food and Drug Administration.
|
| | | Danny Lowe, CMA
Chief Financial Officer Mr. Lowe has extensive experience in corporate finance management with public companies. He currently serves as chief financial officer of Kilgore Minerals Ltd., a mineral exploration company listed on the TSX Venture Exchange of Canada and was the founding chief financial officer of Azure Dynamics Corporation, a public company dual listed on AIM and the TSX Venture Exchange of Canada.
|
| | | Lui Franciosi, PhD
Chief Operating Officer Dr. Franciosi has coordinated many drug and medical device trials in academia and industry for more than 15 years. He has recently completed his post-doctoral research in COPD progression modelling at the Clinical Pharmacology & Discovery Medicine Unit, GlaxoSmithKline, UK and the Leiden/Amsterdam Centre for Drug Research, The Netherlands.
|
| | | David Saint, PhD, MBA
Scientific Advisor Professor Saint has extensive experience as a commercialization consultant for companies and universities in Australia. He is a Professor at the School of Molecular and Biomedical Science, University of Adelaide.
|
|  |  |